R01AG077324
Project Grant
Overview
Grant Description
A Nucleus-to-Mitochondria Nucleic Acid-Sensing Pathway Prevents Bypass of Age-Associated Proliferative Boundaries - Project Summary
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries. The development of immortality as a function of age depends on the ability of cells to escape from at least two distinct proliferative barriers: replicative senescence and crisis. Both barriers serve as critical tumor suppressors, but the pathways governing them are distinct.
Replicative senescence is triggered by short functional telomeres and is dependent on the P53/PRB tumor suppressor pathways. It is characterized by permanent cell cycle arrest and continued metabolism. When the P53/PRB pathways are dysfunctional, senescence entry is compromised, and cells continue to proliferate until their telomeres become dysfunctional and chromosome fusions arise. This triggers replicative crisis, a P53/PRB-independent state, where the vast majority of cells rapidly succumb to cell death.
However, rare cells can overcome this barrier and become neoplastic, indicating that replicative crisis is one of the final barriers against age-associated tumor cell initiation. Recently, it was discovered that cell death in crisis is governed by macroautophagy through a pathway in which cytoplasmic DNA species from fused and broken chromosomes activate the CGAS-STING cytoplasmic DNA-sensing response that normally detects viral DNA. Suppression of autophagy allows cells to bypass crisis and continue to proliferate while accumulating genome instability.
This discovery represented the first crisis-bypass system, which allowed the design of a CRISPR suppression screen aimed at identifying factors required to protect cells against age-associated cancer initiation. Another nucleic acid sensor, ZBP1, emerged as critical for the crisis program, which was confirmed by ZBP1 suppression allowing cells to proliferate beyond crisis.
In three synergistic aims, this project aims to decipher the mechanism underlying the ZBP1-dependent inhibition of cancer initiation. Aim 1 will determine the interactions between dysfunctional telomeres, telomeric (TERRA) transcripts, and ZBP1, and define the mechanisms of ZBP1-mediated innate immune signaling on mitochondria during crisis. Aim 2 is designed to investigate the mechanism of the mitochondrial localization of the crisis-specific isoform of ZBP1 and its relevant interacting partners. Finally, the ability to allow cells to proliferate beyond crisis revealed the existence of a third previously unknown proliferative barrier against cancer initiation (called M3), which will be extensively characterized in Aim 3.
Successful completion of these aims will shed new light on crosstalk between telomeres, mitochondria, and inflammation - three established hallmarks of aging. It will also provide insights into the role of a telomere-to-mitochondria innate immune signaling pathway in the prevention of age-associated cancer and establish biomarkers and new approaches to understand the relevance of the new M3 proliferative barrier as a tumor suppressor.
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries. The development of immortality as a function of age depends on the ability of cells to escape from at least two distinct proliferative barriers: replicative senescence and crisis. Both barriers serve as critical tumor suppressors, but the pathways governing them are distinct.
Replicative senescence is triggered by short functional telomeres and is dependent on the P53/PRB tumor suppressor pathways. It is characterized by permanent cell cycle arrest and continued metabolism. When the P53/PRB pathways are dysfunctional, senescence entry is compromised, and cells continue to proliferate until their telomeres become dysfunctional and chromosome fusions arise. This triggers replicative crisis, a P53/PRB-independent state, where the vast majority of cells rapidly succumb to cell death.
However, rare cells can overcome this barrier and become neoplastic, indicating that replicative crisis is one of the final barriers against age-associated tumor cell initiation. Recently, it was discovered that cell death in crisis is governed by macroautophagy through a pathway in which cytoplasmic DNA species from fused and broken chromosomes activate the CGAS-STING cytoplasmic DNA-sensing response that normally detects viral DNA. Suppression of autophagy allows cells to bypass crisis and continue to proliferate while accumulating genome instability.
This discovery represented the first crisis-bypass system, which allowed the design of a CRISPR suppression screen aimed at identifying factors required to protect cells against age-associated cancer initiation. Another nucleic acid sensor, ZBP1, emerged as critical for the crisis program, which was confirmed by ZBP1 suppression allowing cells to proliferate beyond crisis.
In three synergistic aims, this project aims to decipher the mechanism underlying the ZBP1-dependent inhibition of cancer initiation. Aim 1 will determine the interactions between dysfunctional telomeres, telomeric (TERRA) transcripts, and ZBP1, and define the mechanisms of ZBP1-mediated innate immune signaling on mitochondria during crisis. Aim 2 is designed to investigate the mechanism of the mitochondrial localization of the crisis-specific isoform of ZBP1 and its relevant interacting partners. Finally, the ability to allow cells to proliferate beyond crisis revealed the existence of a third previously unknown proliferative barrier against cancer initiation (called M3), which will be extensively characterized in Aim 3.
Successful completion of these aims will shed new light on crosstalk between telomeres, mitochondria, and inflammation - three established hallmarks of aging. It will also provide insights into the role of a telomere-to-mitochondria innate immune signaling pathway in the prevention of age-associated cancer and establish biomarkers and new approaches to understand the relevance of the new M3 proliferative barrier as a tumor suppressor.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
La Jolla,
California
92037
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 408% from $598,681 to $3,039,544.
San Diego, California Salk Institute For Biological Studies was awarded
Mitochondrial Nucleic Acid-Sensing Pathway Age-Associated Cancer Prevention
Project Grant R01AG077324
worth $3,039,544
from National Institute on Aging in September 2022 with work to be completed primarily in La Jolla California United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/5/26
Period of Performance
9/30/22
Start Date
6/30/27
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01AG077324
Additional Detail
Award ID FAIN
R01AG077324
SAI Number
R01AG077324-2023540132
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
NNJ6BMBTFGN5
Awardee CAGE
6H867
Performance District
CA-50
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,211,963 | 100% |
Modified: 6/5/26